Stocks and Investing Stocks and Investing
Tue, September 3, 2019
Fri, August 30, 2019
Thu, August 29, 2019
Wed, August 28, 2019
Tue, August 27, 2019
Mon, August 26, 2019
Fri, August 23, 2019
Thu, August 22, 2019
Wed, August 21, 2019
Tue, August 20, 2019
Mon, August 19, 2019

Madhu Kumar Maintained (ARWR) at Strong Buy with Increased Target to $46 on, Aug 19th, 2019


Published on 2024-10-26 15:40:18 - WOPRAI, Madhu Kumar
  Print publication without navigation


Madhu Kumar of B. Riley Securities, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy with Increased Target from $32 to $46 on, Aug 19th, 2019.

Madhu has made no other calls on ARWR in the last 4 months.



There is 1 other peer that has a rating on ARWR. Out of the 1 peers that are also analyzing ARWR, all agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Elemer Piros of "Cantor Fitzgerald" Downgraded from Buy to Hold on, Friday, June 28th, 2019